Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
The endpoints of the study are
1. To validate the prognostic significance of OPN in H&N and lung cancer patients and to
monitor its level during active therapy and follow up for cancer surveillance.
2. To identify a gene and protein signature for hypoxia in H&N and lung cancer patients.
Observational Model: Cohort, Time Perspective: Prospective
United States: Food and Drug Administration
|Stanford University School of Medicine||Stanford, California 94305-5317|